In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with dyspnea, a modified position-management protocol significantly improved oxygenation, reduced dyspnea, enhanced comfort, and boosted quality of life compared with conventional postural care. Patients were randomized to the intervention (modified position management) or control (conventional postural care) group, with allocation concealed by an independent statistician and outcome assessors blinded to group assignment; all 150 participants (75 per group) completed the 1-week intervention and were included in the final analysis. After 1 week, the intervention group showed significantly higher PaO2 (82.49 ± 7.81 vs. 76.55 ± 7.11 mmHg; mean difference 5.94 mmHg), SaO2 (90.33 ± 4.69 vs. 84.15 ± 6.95%; mean difference 6.18%), and PaO2/FiO2 (288.50 ± 26.85 vs. 243.40 ± 25.30; mean difference 45.10) compared with control. Modified Borg Scale dyspnea scores were significantly lower in the intervention group (3 [3, 5] vs. 5 [3, 7]), while Kolcaba General Comfort Questionnaire scores were significantly higher (98.24 ± 4.19 vs. 85.17 ± 4.47); Spearman’s correlation revealed a strong negative correlation between dyspnea and comfort scores (r = −0.6362). SF-36 scores across all dimensions were higher in the intervention group, and no intervention-related adverse events were reported, suggesting that modified position management is a safe and effective strategy for improving outcomes in heart failure patients with dyspnea. Source: https://onlinelibrary.wiley.com/
A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…
People with type 2 diabetes (T2D) develop Alzheimer's disease (AD) at a rate of about…
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…
This website uses cookies.